Archives: Speakers

Mark Voigt, Director of Sales at Greenlight Guru, brings over 20 years of experience in software sales. Throughout his career, Mark has focused on understanding and addressing the unique problems and challenges faced by companies, driving solutions that lead to tangible improvements. At Greenlight Guru — the leading provider of quality management and clinical data solutions for medical device companies — Mark helps medical device companies streamline clinical trial data management and bring safer, higher-quality products to market faster.

Alastair has 30+ years of experience in the biopharmaceutical development of pre and post approval drugs.

From 2001-2017, Alastair held a variety of senior positions at AstraZeneca, including as Global Head of Delivery for RWE. Here, he had responsibility for the delivery of both pre and post approval evidence generation programs supporting key assets that have gone on to become world-class products.

From 2017-2024, he worked at Syneos Health, a world-leading Product Development Organisation. As a Senior Vice President of Strategic Alliances, he assisted key clients to clinically develop and successfully commercialise assets, particularly through the generation of RWE.

Now Vice President, Medical Affairs at Sciensus, Alastair successfully helps patients across Europe gain access to treatments and candidate drugs. Enabled by this primary source patient access, data is captured through an innovative digital platform. These real-world insights drive better health outcomes including adherence and patient engagement.

Dr. Raymond A. Huml is the Vice President of Rare & Orphan Disease Strategy at Sciensus, with over 30 years in the healthcare and biopharmaceutical industries. A leader in rare disease research and global due diligence, he has driven nearly $3 billion in capital commitments. A prolific author and award-winning expert, he is dedicated to advancing rare disease innovation, diversity, and global healthcare, including his Peace Corps service in Ghana.

• With over 30 years in the healthcare and biopharmaceutical industries
• Has driven nearly $3 billion in capital commitments
• Prolific author and award-winning expert

Willem Korevaar is Strategic Customer Manager at Adven, responsible for Energy as a Service projects in the Food & Beverage sector. Willem has a background in process engineering and extensive knowledge of beverage industry. He holds a master’s degree in public administration.

Mining Engineer with a master in Energy and Fuels from Universidad Politécnica of Madrid

Energy Risk Professional certificate from Global Association of Risk Professionals (GARP)

11 years professional experience in energy markets (Energy Management, Trading and Origination). The last 3 years working as originator at Statkraft

Jonathan holds a PhD from University College Cork entitled Molecular Interactions in Solutions and Gels of Galactomannans and Carrageenans. Jonathan is currently the Business Development Director for Functional Technologies at Kerry Europe, which include Enzymes, and Brewing Ingredients. He began his career at Kerry in 2007 as part of the R&D team developing new product innovations and now spends his time working with customers to provide solutions that help address current market needs and improve process efficiency while maintaining product quality and consistency.

As leader of the Pitcher Customer Success team, Dirk Abeel applies his broad and deep expertise in sales enablement, commercial excellence, and omnichannel transformation to help our customers successfully execute their commercial strategies on the Pitcher platform

At MED Institute, Samantha leads and supports clinical projects and strategies. She has over 30 years of experience in the medical field, including clinical research, medical education, regulatory affairs, sterile processing, materials management, and surgical technology. She is certified as a Surgical Technologist, Surgical First Assistant, and Clinical Research Professional. She holds a BS in Career and Technical Education from Indiana State University, an AAS in Surgical Technology from Ivy Tech Community College, and is currently pursuing an MPH degree from Purdue Global University.

As an executive in R&D, Technology, Innovation, Product Development and Engineering, I specialize in leading high-impact teams, driving breakthrough product innovation, and transforming cutting-edge research into commercially successful solutions.

With 20+ years of experience, I have scaled multi-million-dollar R&D operations, launched AI-powered products, and led cross-functional teams of engineers, IT, data scientists, and clinicians to bring transformative technologies to market.

Executive Expertise & Leadership Impact:
– AI & Data Strategy – Driving AI, real-world data (RWD), and digital innovations to enhance clinical outcomes.
– R&D Leadership & Innovation – Led end-to-end development of Class II & III medical devices, in-vitro diagnostics, digital health, digital therapeutics, and drug-device combination products.
– Regulatory & Market Access – Deep expertise in FDA, MDR, ISO 13485, ensuring faster product approvals & go-to-market execution.
–  Product Commercialization – Managed $3B+ product portfolios, driving market adoption & revenue growth.
– Strategic Partnerships & GTM Strategy – Spearheading alliances with biopharma, payers, and AI-driven startups.
– Led World Wide Product & Technology Planning that aligned with corporate strategy and goals, by involving cross-